Expert presentation

>15 minutes

Airway Remodeling in Type 2 Asthma Is Driven by IL-4 and IL-13 Signaling Pathways – Dr. Panettieri

Topic: Burden Of Disease Pathophysiology Guidelines & recommendations

Tags: Disease burden  Pathophysiology  Expert opinion  Airway Remodeling 

Airway Remodeling in Type 2 Asthma Is Driven by IL-4 and IL-13 Signaling Pathways – Dr. Panettieri

Video presentation of Dr. Reynold Panettieri discussing how IL-4 and IL-13 drive airway remodeling in type 2 asthma.

 

 

MAT-US-2206444 P- V1 10/07/2024

Welcome to the ADVENT program website

ADVENT is a medical education program by Sanofi and Regeneron. This website is intended only for health care professionals in the US only.

I AM A HEALTHCARE PROVIDER
I AM NOT A HEALTHCARE PROVIDER

ADVENT is a global medical education program by Sanofi and Regeneron and is only intended for healthcare providers.

You are leaving the ADVENT program website

Sanofi Genzyme does not review or control the content of non–Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of the site’s content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non–Sanofi Genzyme website.

LEAVE THIS SITE GO BACK TO ADVENT PROGRAM
x

STAY IN THE KNOW

Would you like to receive updates on new ADVENT content, courses and events when available?

SUBSCRIBE

MAT-US-2104233 Exp 04/26/2023

x

Congratulations, you are now subscribed successfully.

You will receive a confirmation email at the address you provided.

If you don’t receive it, please check your spam.